Manuel Sánchez-Cánovas

12PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 03, 2025
Correction: PARP inhibitors‑associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Manuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo

|Sep 07, 2025
PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Manuel Sánchez Cánovas, Javier López Robles, Francisco José García Verdejo

|Jun 21, 2024
Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.

Manuel Sánchez Cánovas, Miguel Ángel Moya Hernández, Evdochia Adoamnei

|Jun 12, 2024
Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?

Manuel Sánchez Cánovas, Esmeralda García Torralba, Noel Blaya Boluda

|Jan 29, 2024
Endoscopic intervention as a decisive tool in the prognosis of cancer patients.

Manuel Sánchez Cánovas, Javier López Robles, Marina Lozano Ros

Pageof 2